Ad
related to: abbvie- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- Read AbbVie Stories
Search results
A company insider recently sold 21,082 shares of Abbvie Inc [ABBV]. Should You Sale? – Knox Daily
Knox Daily· 21 hours agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abbvie Inc shares valued at $3,716,757 were sold ...
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc
GuruFocus.com via Yahoo Finance· 4 days agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and...
Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?
Zacks via Yahoo Finance· 2 days agoInvestors in AbbVie Inc. ABBV need to pay close attention to the stock based on moves in the options...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 2 days agoWhen others think the outlook for a stock isn't so great, you can win big if that view is overly pessimistic. Several stocks that pay fantastic dividends...
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Motley Fool via Yahoo Finance· 6 days agoThere are magnificent stocks to buy in other industries, such as healthcare, which may provide...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 7 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately ...
AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...
Valley City Times Record· 4 days agoNew safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class c-Met directed ...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar· 5 days agoAlmost a dozen pharmaceutical companies, including several major players, have lost sensitive...
The Lash Group Notifies Consumers of Massive Data Breach Leaking Their Sensitive Medical Information...
JD Supra· 4 days agoIn this notice, Lash Group explains that the incident resulted in an unauthorized party being able to access consumers’ sensitive information, which includes their first names, last names, dates ...